Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-09 @ 7:47 PM
Study NCT ID:
NCT03849105
Status:
COMPLETED
Last Update Posted:
2023-04-14
First Post:
2019-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
131I-IPA and Concurrent XRT in Recurrent GBM
Sponsor:
Telix Pharmaceuticals (Innovations) Pty Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-29
First Submit QC Date:
None
Study First Post Date:
2019-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-12
Last Update Post Date:
2023-04-14
Last Update Post Date Type:
ACTUAL